Literature DB >> 14695184

Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: implications for tumor promotion.

Yang-Sook Chun1, Kyoung-Hwa Lee, Eunjoo Choi, Soo-Young Bae, Eun-Jin Yeo, L Eric Huang, Myung-Suk Kim, Jong-Wan Park.   

Abstract

Hypoxia-inducible factor-1 (HIF-1), which is present at higher levels in human tumors, plays important roles in tumor promotion. It is composed of HIF-1alpha and HIF-1beta subunits and its activity depends on the amount of HIF-1alpha, which is tightly controlled by cellular oxygen tension. In addition to hypoxia, various nonhypoxic stimuli can stabilize HIF-1alpha in tumor cells, implying that both hypoxic and nonhypoxic stimuli contribute to the overexpression of HIF-1alpha in tumors. On the other hand, phorbol esters such as phorbol-12-myristate-13-acetate (PMA) are known to be potent tumor promoters. Here, we identified a novel HIF-1alpha isoform, which is regulated primarily by PMA. The variant mRNA lacks exon 11 and produces a 785-amino acid isoform (HIF-1alpha(785)) without altering the reading frame and therefore the COOH-terminal transcriptional activity. HIF-1alpha(785) is induced markedly by PMA and heat shock, the latter of which is also known to induce HIF-1alpha. HIF-1alpha(785) escapes from lysine acetylation because of the loss of Lys(532) and was stabilized under normoxic conditions. Its expression was blocked by reducing agents and by a mitogen-activated protein/extracellular signal-regulated kinase-1 inhibitor and enhanced by hydrogen peroxide. In addition, HIF-1alpha(785) overexpression strikingly enhanced tumor growth in vivo. These results suggest that HIF-1alpha(785) is induced by PMA under normoxic conditions via a redox-dependent mitogen-activated protein/extracellular signal-regulated kinase-1 pathway and that it plays an important role in tumor promotion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695184

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.

Authors:  Madhuri Ramanathan; Grace Pinhal-Enfield; Irene Hao; Samuel Joseph Leibovich
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

Review 2.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  HIF-1alpha: a valid therapeutic target for tumor therapy.

Authors:  Soon-Sun Hong; Hyunseung Lee; Kyu-Won Kim
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

Review 4.  Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.

Authors:  Balveen Kaur; Fatima W Khwaja; Eric A Severson; Shannon L Matheny; Daniel J Brat; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

Review 5.  Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!

Authors:  T Gaber; R Dziurla; R Tripmacher; G R Burmester; F Buttgereit
Journal:  Ann Rheum Dis       Date:  2005-03-30       Impact factor: 19.103

6.  Regulation of the Warburg effect in early-passage breast cancer cells.

Authors:  Ian F Robey; Renu M Stephen; Kathy S Brown; Brenda K Baggett; Robert A Gatenby; Robert J Gillies
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

7.  HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.

Authors:  Nastaran Monsef; Maria Soller; Ioannis Panagopoulos; Per Anders Abrahamsson
Journal:  BMC Cancer       Date:  2010-07-21       Impact factor: 4.430

8.  Hypoxia inducible factor 1alpha gene (HIF-1alpha) splice variants: potential prognostic biomarkers in breast cancer.

Authors:  Jean-Philippe Dales; Nathalie Beaufils; Monique Silvy; Christophe Picard; Vanessa Pauly; Vincent Pradel; Christine Formisano-Tréziny; Pascal Bonnier; Sophie Giusiano; Colette Charpin; Jean Gabert
Journal:  BMC Med       Date:  2010-07-12       Impact factor: 8.775

9.  Non-hypoxic transcriptional activation of the aryl hydrocarbon receptor nuclear translocator in concert with a novel hypoxia-inducible factor-1alpha isoform.

Authors:  Kyoung-Hwa Lee; Jong-Wan Park; Yang-Sook Chun
Journal:  Nucleic Acids Res       Date:  2004-10-12       Impact factor: 16.971

10.  Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase.

Authors:  Dong Hoon Shin; Yang-Sook Chun; Kyoung-Hwa Lee; Hyun-Woo Shin; Jong-Wan Park
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.